Sign Up Today and Learn More About Cognito Therapeutics Stock
Invest in or calculate the value of your shares in Cognito Therapeutics or other pre-IPO companies through EquityZen's platform.
Cognito Therapeutics Stock (COGT)
Cognito Therapeutics is a neurotechnology company that is developing disease-modifying treatments for CNS illnesses.
About Cognito Therapeutics Stock
Founded
2016
Headquarters
Cambridge, MA, US
Industries
Science and Engineering, Health Care, Biotechnology
Cognito Therapeutics Press Mentions
Stay in the know about the latest news on Cognito Therapeutics
Cognito Therapeutics Presents Early-Stage Cost-Effectiveness Analysis of Spectris™ Therapy in Alzheimer’s Disease at ISPOR 2024
businesswire • Nov 19, 2024
Cognito Therapeutics Names New CEO
mpo-mag • Sep 20, 2024
Cognito Therapeutics Appoints Christian Howell as Chief Executive Officer
businesswire • Aug 26, 2024
Cognito Therapeutics Announce OVERTURE I Study Demonstrated Significant Time Savings Using Composite Measures of Function and Cognition
finance • Aug 02, 2024
Cognito Therapeutics Announces Scientific Presentations at the Alzheimer’s Association International Conference 2024
businesswire • Aug 02, 2024
Cognito Therapeutics Management
Leadership team at Cognito Therapeutics
President
Zach Malchano
VP, BD and Strategic Partnerships
Martin Williams
Join now and verify your accreditation status to gain access to:
- Cognito Therapeutics current valuation
- Cognito Therapeutics stock price
- Available deals in Cognito Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Cognito Therapeutics Stock
How to invest in Cognito Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Cognito Therapeutics through EquityZen funds. These investments are made available by existing Cognito Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Cognito Therapeutics stock?
Shareholders can sell their Cognito Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
